← back to search

Shan Zheng

Beijing Center for Disease Prevention and Control · CN
Area of research
Surgery · Pulmonary and Respiratory Medicine
Research interest
Research interests include Pediatric Hepatobiliary Diseases and Treatments, Gallbladder and Bile Duct Disorders, Congenital Anomalies and Fetal Surgery, and Intestinal Malrotation and Obstruction Disorders.
h-index
42
citations
8,490
works
437
NIH funding
primary concept
Medicine
email

Recent publications

RNA m6A methylation regulates CDH6 to promote epithelial-to-mesenchymal transition in cholangiocytes of biliary atresia.
2026cited by 0position: contributordoi
Single-cell transcription reveals hepatocyte-to-cholangiocyte reprogramming and biliary gene profile in biliary atresia.
2025cited by 4position: contributordoi
LncRNA MEG9 Promotes Inflammation and Liver Fibrosis Through S100A9 in Biliary Atresia.
2025cited by 3position: contributordoi
Development and validation of a minimally invasive diagnostic model for biliary atresia using artificial intelligence.
2025cited by 1position: contributordoi
CXCL6 Is a Novel Biliary Marker and a Downstream Target of MMP7 in Biliary Atresia.
2025cited by 1position: contributordoi
Serum FGF19 combined with GGT and other biomarkers predicted native liver survival following Kasai portoenterostomy in early biliary atresia.
2025cited by 0position: contributordoi
Clinical Course and Outcome of COVID-19 in Children With Biliary Atresia: A Retrospective Study.
2025cited by 0position: contributordoi
Progress in Biomarkers Related to Biliary Atresia.
2024cited by 14position: contributordoi
Serum matrix metalloproteinase-7 for discriminating biliary atresia: a diagnostic accuracy and validation study.
2024cited by 10position: contributordoi
Analysis of false reasons based on the artificial intelligence RRCART model to identify frozen sections of lymph nodes in breast cancer
Diagnostic Pathology 2024cited by 3position: middledoi
NLRP3 inflammasome activation promotes liver inflammation and fibrosis in experimental biliary atresia.
2024cited by 1position: contributordoi
Incidence and outcome of biliary atresia in Shanghai, China from 2015 to 2016: a cohort study.
2024cited by 0position: contributordoi
Intestinal fibrosis in aganglionic segment of Hirschsprung's disease revealed by single-cell RNA sequencing.
2023cited by 16position: contributordoi
Effect of Adjuvant Steroid Therapy in Type 3 Biliary Atresia: A Single-Center, Open-Label, Randomized Controlled Trial.
2023cited by 15position: contributordoi
Integrative analysis implicates the significance of m6A in the liver fibrosis of biliary atresia by regulating THY1.
2023cited by 15position: contributordoi
Biliatresone: progress in biliary atresia study.
2023cited by 12position: contributordoi
Single-cell and spatial transcriptomics reveal the fibrosis-related immune landscape of biliary atresia.
2022cited by 46position: contributordoi
Characteristics of SOX9-positive progenitor-like cells during cholestatic liver regeneration in biliary atresia.
2022cited by 14position: contributordoi
Preventive effect of prophylactic intravenous antibiotics against cholangitis in biliary atresia: a randomized controlled trial.
2021cited by 8position: contributordoi
Epidemiological characteristics and risk factors of biliary atresia: a case-control study.
2021cited by 6position: contributordoi
Protocol for a diagnostic accuracy study to develop diagnosis algorithm for biliary atresia using MMP-7 (DIABA-7 study): a study recruiting from Chinese Biliary Atresia Collaborative Network
BMJ Open 2021cited by 3position: contributordoi
Gut microbial profile in biliary atresia: a case-control study.
2020cited by 39position: contributordoi
The synthetic toxin biliatresone causes biliary atresia in mice.
2020cited by 26position: contributordoi
Modelling liver cancer initiation with organoids derived from directly reprogrammed human hepatocytes
Nature Cell Biology 2019cited by 161position: middledoi
Modelling liver cancer initiation with organoids derived from directly reprogrammed human hepatocytes.
2019cited by 126position: contributordoi
Serum MMP-7 in the Diagnosis of Biliary Atresia.
2019cited by 81position: contributordoi
Risk factors and prognostic effects of cholangitis after Kasai procedure in biliary atresia patients: A retrospective clinical study.
2019cited by 40position: contributordoi
Reoperation after Ladd's procedure in the neonatal period.
2019cited by 22position: contributordoi
Clinical characteristics and prognosis of adrenocortical tumors in children.
2019cited by 14position: contributordoi
Correlation between hepatic oxidative damage and clinical severity and mitochondrial gene sequencing results in biliary atresia.
2019cited by 10position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 23 papers (2019–2026)Junfeng Wang · Children's Hospital of Fudan University4 papers (2023–2025) · 4 papers (2023–2025)Weili Yan · Ministry of Education3 papers (2021–2024)Yuan Ji · Sun Yat-sen University2 papers (2019–2019)Xianmin Xiao · Children's Hospital of Fudan University2 papers (2013–2014) · 2 papers (2023–2025)Lingdu Meng · Children's Hospital of Fudan University2 papers (2023–2025)Zhen Shen · Children's Hospital of Fudan University2 papers (2024–2025) · 2 papers (2021–2024)Shiwei He · Fudan University2 papers (2021–2023)Gong Chen · Children's Hospital of Fudan University2 papers (2023–2025)Fanyang Kong · 2 papers (2025–2025) · 1 papers (2024–2024)Zhixin Qiu · Sichuan University1 papers (2019–2019)Hong Li · Third People's Hospital of Chengdu1 papers (2019–2019)Lei Guo · The Ohio State University1 papers (2024–2024)Le Wang · Jiangsu University1 papers (2019–2019)Haibin Zhang · South China Agricultural University1 papers (2019–2019)Kwok Yan Li · Fudan University1 papers (2014–2014)